Radiolabeled Study to Determine the Mass Balance of [14C] MGL-3196
Clinical trial NCT03220165 · COMPLETED
Trial details
- NCT number
- NCT03220165
- Sponsor
- Madrigal Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-06
- Primary completion
- 2017-09-03
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.